15.90
price down icon3.23%   -0.53
after-market 시간 외 거래: 15.90
loading
전일 마감가:
$16.43
열려 있는:
$16.42
하루 거래량:
342.82K
Relative Volume:
0.46
시가총액:
$458.92M
수익:
$66.59M
순이익/손실:
$-104.93M
주가수익비율:
-3.2121
EPS:
-4.95
순현금흐름:
$-96.48M
1주 성능:
+1.21%
1개월 성능:
+12.61%
6개월 성능:
+112.00%
1년 성능:
+171.79%
1일 변동 폭
Value
$15.80
$16.88
1주일 범위
Value
$15.80
$17.15
52주 변동 폭
Value
$4.09
$17.15

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
명칭
Enanta Pharmaceuticals Inc
Name
전화
617 607 0800
Name
주소
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
직원
120
Name
트위터
@EnantaPharma
Name
다음 수익 날짜
2025-02-10
Name
최신 SEC 제출 서류
Name
ENTA's Discussions on Twitter

ENTA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
15.90 474.21M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
453.74 116.65B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
773.94 82.03B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.25 52.69B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
837.90 51.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
174.09 37.61B 447.02M -1.18B -906.14M -6.1812

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-11-14 개시 JP Morgan Overweight
2025-10-01 업그레이드 Jefferies Hold → Buy
2025-07-28 재개 H.C. Wainwright Buy
2023-08-09 다운그레이드 JP Morgan Neutral → Underweight
2023-08-08 다운그레이드 Jefferies Buy → Hold
2022-12-09 개시 H.C. Wainwright Buy
2022-07-06 업그레이드 Evercore ISI In-line → Outperform
2022-06-01 업그레이드 Evercore ISI Underperform → In-line
2021-10-07 개시 Jefferies Buy
2021-09-09 개시 SVB Leerink Mkt Perform
2021-01-29 업그레이드 JP Morgan Underweight → Neutral
2020-11-24 개시 Evercore ISI Underperform
2020-08-28 재개 ROTH Capital Buy
2020-08-26 개시 Piper Sandler Overweight
2020-07-27 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 업그레이드 Robert W. Baird Neutral → Outperform
2019-11-22 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 다운그레이드 JP Morgan Neutral → Underweight
2019-05-24 개시 Wolfe Research Outperform
2019-04-23 업그레이드 Berenberg Hold → Buy
2018-12-13 개시 Berenberg Hold
2018-06-06 개시 ROTH Capital Buy
2018-02-08 다운그레이드 JP Morgan Overweight → Neutral
2018-01-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2017-11-21 재확인 RBC Capital Mkts Outperform
2017-09-15 개시 RBC Capital Mkts Outperform
2017-07-11 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 재확인 Barclays Underweight
2015-10-23 다운그레이드 Barclays Equal Weight → Underweight
2015-10-23 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
모두보기

Enanta Pharmaceuticals Inc 주식(ENTA)의 최신 뉴스

pulisher
Dec 24, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsTrend Following Strategies & Affordable Trading Portfolio - Bollywood Helpline

Dec 24, 2025
pulisher
Dec 22, 2025

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? - Yahoo Finance

Dec 22, 2025
pulisher
Dec 21, 2025

What hedge fund activity signals for Enanta Pharmaceuticals Inc. stock2025 Market Outlook & Daily Growth Stock Investment Tips - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

How Enanta Pharmaceuticals Inc. stock performs in interest rate cycles2025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Does Enanta Pharmaceuticals Inc. stock trade at a discount to peersMarket Movement Recap & Smart Allocation Stock Tips - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st

Dec 20, 2025
pulisher
Dec 20, 2025

Rate Hike: Will Enanta Pharmaceuticals Inc. stock see insider buyingTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Will Enanta Pharmaceuticals Inc. (9EP) stock see insider accumulationTrade Risk Report & Long-Term Safe Investment Ideas - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

What margin trends mean for Enanta Pharmaceuticals Inc. stockJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Enanta Pharmaceuticals Inc. stock is considered a top pickMarket Activity Summary & Precise Trade Entry Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from upcoming earnings reportsRate Hike & Accurate Technical Buy Alerts - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 19, 2025

Aug Breakouts: Will Enanta Pharmaceuticals Inc. (9EP) stock outperform Dow Jones2025 Market Sentiment & Weekly High Momentum Picks - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Enanta Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Retail & Low Drawdown Momentum Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from automation2025 Earnings Impact & AI Based Buy/Sell Signal Reports - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Enanta Pharmaceuticals Inc. stock see insider buyingMarket Trend Report & Fast Exit and Entry Strategy Plans - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Enanta Pharmaceuticals Inc. stock appeals to analystsStop Loss & Expert Approved Trade Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Is Enanta Pharmaceuticals Inc. stock trading at a premium valuation2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда

Dec 18, 2025
pulisher
Dec 15, 2025

(ENTA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Dec 15, 2025
pulisher
Dec 13, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat

Dec 13, 2025
pulisher
Dec 08, 2025

Have Insiders Sold Enanta Pharmaceuticals Shares Recently? - simplywall.st

Dec 08, 2025
pulisher
Dec 08, 2025

Enanta Pharmaceuticals falls on public offering of common stock - MSN

Dec 08, 2025
pulisher
Dec 06, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay Luly Sells 4,743 Shares of Stock - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Enanta Pharma chief medical officer sells $11k in stock By Investing.com - Investing.com Canada

Dec 06, 2025
pulisher
Dec 06, 2025

Tara Lynn Kieffer Sells 2,106 Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) Stock - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Enanta Pharma CBO Luu sells $19,836 in stock By Investing.com - Investing.com Canada

Dec 05, 2025
pulisher
Dec 05, 2025

Enanta Pharma CBO Luu sells $19,836 in stock - Investing.com India

Dec 05, 2025
pulisher
Dec 05, 2025

Enanta Pharma CSO Or Yat Sun sells $34k in stock - Investing.com India

Dec 05, 2025
pulisher
Dec 05, 2025

Enanta Pharma CSO Or Yat Sun sells $34k in stock By Investing.com - Investing.com South Africa

Dec 05, 2025
pulisher
Dec 05, 2025

Enanta Pharma chief product officer sells $30k in stock By Investing.com - Investing.com UK

Dec 05, 2025
pulisher
Dec 05, 2025

Will Enanta Pharmaceuticals Inc. (9EP) stock extend growth storyJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Can Enanta Pharmaceuticals Inc. (9EP) stock survive global slowdownJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Enanta Pharmaceuticals Inc. (9EP) stock nearing a technical breakout - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Enanta Pharmaceuticals Inc. stock a top momentum playQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

VP Or Surrenders 753 Of Enanta Pharmaceuticals Inc [ENTA] - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

ENTA: RSV and immunology pipelines advance with key candidates and pivotal trials planned for 2026 - TradingView

Dec 03, 2025
pulisher
Dec 02, 2025

Is Enanta Pharmaceuticals Inc. (9EP) stock a defensive play amid uncertainty - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 30, 2025
pulisher
Nov 29, 2025

Certain Options of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025
pulisher
Nov 29, 2025

Certain Common Stock of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025
pulisher
Nov 29, 2025

Portfolio Recap: What makes Enanta Pharmaceuticals Inc. stock attractive to growth funds2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - moha.gov.vn

Nov 29, 2025
pulisher
Nov 29, 2025

Enanta Pharmaceuticals Inc Stock Analysis and ForecastMarket Capitalization Trends & Free Unmatched Market Performance - earlytimes.in

Nov 29, 2025
pulisher
Nov 27, 2025

Enanta Pharmaceuticals, Inc. (ENTA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 27, 2025
pulisher
Nov 26, 2025

Enanta Pharmaceuticals insider awarded RSUs and 12,925 stock options - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

[Form 4] ENANTA PHARMACEUTICALS INC Insider Trading Activity - Stock Titan

Nov 26, 2025

Enanta Pharmaceuticals Inc (ENTA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$38.99
price down icon 0.23%
$31.49
price down icon 3.17%
$98.91
price down icon 0.38%
$95.28
price up icon 0.08%
biotechnology ONC
$304.72
price down icon 1.80%
$174.09
price down icon 1.28%
자본화:     |  볼륨(24시간):